Clinical trial
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma…
NCT00053898 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00053898 |
|---|---|
| Title | Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy |
| Official title | A Clinical Trial Comparing Anastrozole With Tamoxifen in Postmenopausal Patients With Ductal Carcinoma in Situ (DCIS) Undergoing Lumpectomy With Radiation Therapy |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group SWOG Cancer Research Network American College of Surgeons |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Radiation |
| Interventions | anastrozole, tamoxifen citrate, Radiation Therapy |
| Enrollment | 3,104 |
| Start date | Jan 1, 2003 |
| Primary completion | Mar 1, 2015 |
| Completion | May 1, 2016 |
| First posted | Feb 6, 2003 |
| Last update posted | Sep 20, 2018 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: